A detailed history of Schulhoff & CO Inc transactions in Amgen Inc stock. As of the latest transaction made, Schulhoff & CO Inc holds 844 shares of AMGN stock, worth $269,725. This represents 0.13% of its overall portfolio holdings.

Number of Shares
844
Previous 844 -0.0%
Holding current value
$269,725
Previous $239,000 10.04%
% of portfolio
0.13%
Previous 0.11%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$255.7 - $288.46 $20,456 - $23,076
-80 Reduced 8.66%
844 $243,000
Q2 2023

Aug 01, 2023

SELL
$214.27 - $253.37 $25,283 - $29,897
-118 Reduced 11.32%
924 $205,000
Q2 2021

Aug 03, 2021

BUY
$233.58 - $259.14 $21,255 - $23,581
91 Added 9.57%
1,042 $253,000
Q2 2020

Jul 29, 2020

BUY
$197.81 - $242.74 $188,117 - $230,845
951 New
951 $224,000
Q1 2020

Apr 30, 2020

SELL
$182.24 - $241.7 $173,310 - $229,856
-951 Closed
0 $0
Q4 2019

Jan 31, 2020

BUY
$189.21 - $243.2 $179,938 - $231,283
951 New
951 $229,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Schulhoff & CO Inc Portfolio

Follow Schulhoff & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schulhoff & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schulhoff & CO Inc with notifications on news.